Login / Signup

Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trial.

Jingyuan LiSicong MaXiu JiaYingzhen BuTienan ZhouLei ZhangMiaohan QiuXiao-Zeng Wang
Published in: Trials (2023)
ChiCTR2100051990, ClinicalTrials.gov, registered on 12 October 2021.
Keyphrases
  • abdominal aortic aneurysm
  • venous thromboembolism
  • atrial fibrillation
  • pulmonary embolism